Saturday, October 31, 2026

Benchmark Electronics And 3 Other Stocks Have Very High Payout Ratio

ViaNews Editorial Team

December 9, 2021

Benchmark Electronics And 3 Other Stocks Have Very High Payout Ratio

(VIANEWS) - Benchmark Electronics (BHE), Blackrock MuniYield California Quality Fund (MCA), Manulife Financial (MFC) are the highest payout ratio stocks on this list.

We have gathered information regarding stocks with the highest payout ratio up until now. The payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.

1. Benchmark Electronics (BHE)

81.65% Payout Ratio

Benchmark Electronics, Inc., together with its subsidiaries, provides product design, engineering services, technology solutions, and advanced manufacturing services in the Americas, Asia, and Europe.

Volume

Today's last reported volume for Benchmark Electronics is 178548, 6.16% above its average volume of 168180.

According to Morningstar, Inc., the next dividend payment is on Sep 28, 2021, the estimated forward annual dividend rate is 0.66 and the estimated forward annual dividend yield is 2.45%.

Benchmark Electronics's sales growth this year is anticipated to be 7.9% and 5.5% for next year.

Year-on-year quarterly revenue growth grew by 10.9%, now sitting on 2.1B for the twelve trailing months.

Benchmark Electronics's sales growth is 13.6% for the ongoing quarter and 12.1% for the next. The company's growth estimates for the ongoing quarter and the next is 18.8% and 20.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 2.96%.

Volatility

Benchmark Electronics's last day, week, and month's current intraday variation average was 0.12%, 0.23%, and 1.47%, respectively.

Benchmark Electronics's highest amplitude of average volatility was 1.48% (day), 1.86% (last week), and 2.87% (last month), respectively.

Benchmark Electronics's Stock Yearly Top and Bottom Value

Benchmark Electronics's stock is valued at $26.06 at 13:23 EST, way below its 52-week high of $32.56 and way above its 52-week low of $22.25.

Benchmark Electronics's Moving Average

Benchmark Electronics's worth is under its 50-day moving average of $26.08 and below its 200-day moving average of $28.05.

2. Blackrock MuniYield California Quality Fund (MCA)

78.85% Payout Ratio

BlackRock MuniYield California Quality Fund, Inc. is a closed ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC.

Volume

Today's last reported volume for Blackrock MuniYield California Quality Fund is 30839, 44.02% below its average volume of 55093.

According to Morningstar, Inc., the next dividend payment is on Jul 13, 2021, the estimated forward annual dividend rate is 0.67 and the estimated forward annual dividend yield is 4.24%.

Year-on-year quarterly revenue growth declined by 5.9%, now sitting on 32.13M for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.39%.

Volatility

Blackrock MuniYield California Quality Fund's last day, week, and month's current intraday variation average was 0.39%, 0.83%, and 0.71%, respectively.

Blackrock MuniYield California Quality Fund's highest amplitude of average volatility was 0.90% (day), 1.25% (last week), and 1.24% (last month), respectively.

Blackrock MuniYield California Quality Fund's Stock Yearly Top and Bottom Value

Blackrock MuniYield California Quality Fund's stock is valued at $-0.11 at 13:23 EST, way below its 52-week low of $14.29.

Blackrock MuniYield California Quality Fund's Moving Average

Blackrock MuniYield California Quality Fund's value is way under its 50-day moving average of $15.59 and way under its 200-day moving average of $15.40.

3. Manulife Financial (MFC)

30.77% Payout Ratio

Manulife Financial Corporation, together with its subsidiaries, provides financial advice, insurance, and wealth and asset management solutions for individuals, groups, and institutions in Asia, Canada, the United States, and internationally.

Volume

Today's last reported volume for Manulife Financial is 447087, 87.78% below its average volume of 3660590.

As claimed by Morningstar, Inc., the next dividend payment is on Aug 15, 2021, the estimated forward annual dividend rate is 0.89 and the estimated forward annual dividend yield is 4.52%.

Manulife Financial's sales growth this year is expected to be negative 9.6% and 5.3% for next year.

Year-on-year quarterly revenue growth declined by 6.7%, now sitting on 53.57B for the twelve trailing months.

Manulife Financial's sales growth is negative 11.7% for the current quarter and negative 27.6% for the next. The company's growth estimates for the current quarter and the next is 19% and 13.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.32%.

Volatility

Manulife Financial's last day, week, and month's current intraday variation average was 0.27%, 0.27%, and 0.96%, respectively.

Manulife Financial's highest amplitude of average volatility was 0.90% (day), 0.91% (last week), and 1.55% (last month), respectively.

Manulife Financial's Stock Yearly Top and Bottom Value

Manulife Financial's stock is valued at $18.72 at 13:23 EST, way below its 52-week high of $22.25 and way higher than its 52-week low of $15.59.

Manulife Financial's Moving Average

Manulife Financial's worth is under its 50-day moving average of $19.77 and below its 200-day moving average of $19.97.

4. Ralph Lauren Corporation (RL)

30.15% Payout Ratio

Ralph Lauren Corporation designs, markets, and distributes lifestyle products in North America, Europe, Asia, and internationally.

Volume

Today's last reported volume for Ralph Lauren Corporation is 1365660, 60.75% above its average volume of 849537.

As claimed by Morningstar, Inc., the next dividend payment is on Sep 22, 2021, the estimated forward annual dividend rate is 2.75 and the estimated forward annual dividend yield is 2.35%.

Ralph Lauren Corporation's sales growth this year is expected to be 31.1% and 4.4% for next year.

Year-on-year quarterly revenue growth grew by 182.3%, now sitting on 5.29B for the twelve trailing months.

The company's growth estimates for the present quarter and the next is 38.2% and 36.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.5%.

Volatility

Ralph Lauren Corporation's last day, week, and month's current intraday variation average was 2.65%, 2.39%, and 2.26%, respectively.

Ralph Lauren Corporation's highest amplitude of average volatility was 4.12% (day), 3.34% (last week), and 3.42% (last month), respectively.

Ralph Lauren Corporation's Stock Yearly Top and Bottom Value

Ralph Lauren Corporation's stock is valued at $0.00 at 13:23 EST, below its 52-week low of $85.81.

Ralph Lauren Corporation's Moving Average

Ralph Lauren Corporation's worth is under its 50-day moving average of $120.40 and below its 200-day moving average of $120.48.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com